Geisinger testing AI-powered vocal biomarker that identifies COPD flare-ups

Listen

Danville, Pa.-based Geisinger launched a study to test an algorithm for vocal biomarkers that can help detect exacerbations in chronic obstructive pulmonary disease patients.

The one-year research study examines artificial intelligence-powered voice analysis technology created by Healthymize, a health information technology startup. Study participants are required to perform daily voice recordings and fill out questionnaires to monitor their COPD.

"If we detect changes in a patient's health condition earlier, we can reduce hospitalization and administer care in a timely manner at home," said Paul F. Simonelli, MD, PhD, chair of pulmonary and critical care medicine at Geisinger, according to a news release. "We know that early detection of exacerbation improves outcomes, and Healthymize has the potential to present an easy-to-use solution that monitors patients from home."

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars